(A)Diagram illustrating S.Typhimurium infection and RA treatment timeline. 24 hours prior to infection, mice were treated with 20mg of streptomycin via oral gavage, followed by 108cfu/mL 24 post streptomycin. 250µg RA was administered twice intraperitoneally to Rdh7∆IEC. Mice were sacrificed 72 hours post infection.
(B) Quantification of S. Typhimurium bacterial burden in feces from streptomycin treated Rdh7fl/fl, Rdh7∆IEC and Rdh7∆IEC+RA mice at 72 hours post infection.
(C)
S. Typhimurium burden in spleen after 72 hours post infection Rdh7fl/fl, Rdh7∆IEC and Rdh7∆IEC+RA streptomycin treated mice.
(D) mRNA quantification of Il-22 in the colon of Rdh7fl/fl, Rdh7∆IEC and Rdh7∆IEC+RA streptomycin treated mice 72 hours post infection with S. Typhimurium.
(E) mRNA quantification of IL-22 dependent antimicrobials, Reg3γ and calprotectin subunits S100A8 and S100A9 in the colon of Rdh7fl/fl, Rdh7∆IEC and Rdh7∆IEC+RA mice 72 hours post infection with S. Typhimurium.
All the mice used for this experiment were littermate controls that were co-housed before infection and housed separately after infection (N=6). Figures represent an individual experiment that was repeated four times. Error bar represent SEM. One-way ANOVA. *P < 0.05, **P < 0.01 and ***P < 0.001.
Also see Figure S5